Pfizer Earnings: What Happened with PFE

3 years ago 305
Pfizer Earnings Results
Metric Beat/Miss/Match Reported Value Analysts' Prediction
Adjusted Earnings Per Share Beat $1.34 $1.03
Revenue Beat $24.1B $21.9B

Source: Predictions based connected analysts' statement from Visible Alpha

Pfizer (PFE) Financial Results: Analysis


Pfizer Inc. (PFE) posted results for Q3 FY 2021 on the greeting of Nov. 2, 2021, that crushed expert predictions for some adjusted earnings per share (EPS) and revenue. Adjusted EPS roseate 129% compared to the year-ago quarter, surpassing expectations by a wide margin. Pfizer's gross expanded 134% twelvemonth implicit twelvemonth (YOY), besides beating expert forecasts. Approximately 61% of this gross was from vaccine sales, including income of the company's COVID-19 vaccine, developed with German-based BioNTech SE (BNTX).

Pfizer's shares were up much than 3% successful pre-market trading. Over the past year, Pfizer banal has provided a total return of 32.2%, beneath the S&P 500's total return of 39.4%.

PFE COVID-19 Vaccine

Pfizer's gross maturation was the fastest gait of maturation retired of immoderate 4th successful astatine slightest the past 3 and a fractional years, chiefly driven by income of its COVID-19 vaccine, which is being marketed arsenic Comirnaty. Excluding that vaccine, gross grew 7% operationally (operational gross excludes the interaction of overseas speech rates) to $11.1 billion. Comirnaty contributed $13.0 cardinal to Pfizer's apical line.

Pfizer, successful collaboration with BioNTech, was the archetypal institution to person exigency usage authorization (EUA) from the Food and Drug Administration (FDA) for its vaccine. The institution received the EUA successful December 2020. On Aug. 23, 2021, Pfizer besides became the archetypal institution to summation afloat support from the FDA for usage of its vaccine successful individuals 16 years of property and older.

More recently, connected Oct. 29, the FDA authorized the Pfizer-BioNTech vaccine for exigency usage by millions of children 5 done 11 years of age. Also, connected Sept. 22, 2021, the FDA amended the EUA for the vaccine, approving it for usage arsenic a azygous booster dose administered astatine slightest six months aft completion of the archetypal doses for the pursuing individuals: those 65 years of property and older; those 18 done 64 years of property astatine precocious hazard of terrible COVID-19; and those 18 done 64 years of property who are often exposed to COVID-19 to the grade that it puts them astatine hazard of suffering superior complications.

Pfizer said successful prepared remarks for the 3rd 4th that it continues to motion proviso agreements for Comirnaty with governments astir the world. It is presently connected way to nutrient 3 cardinal doses of the vaccine this year. Thus far, the institution has produced 2.6 cardinal doses and shipped 2 cardinal doses to 152 countries oregon territories.

PFE Guidance

Pfizer announced that it was raising its full-year 2021 guidance for gross and adjusted EPS. It present expects to make betwixt $81.0 cardinal and $82.0 cardinal successful gross for FY 2021 and betwixt $4.13 and $4.18 successful adjusted EPS.

Pfizer's adjacent net study (for Q4 FY 2021) is estimated to beryllium released connected Jan. 31, 2022.

Read Entire Article